NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









KromaTiD

KromaTiD

Private
Boulder, ColoradoHealthcare & Life Scienceshttps://kromatid.com/

Last Round

Series C

Aug 20, 2025

Total Funding Raised

$14.21M

Company Overview

KromaTiD is a biotechnology company that provides proprietary single-cell genomic structural analysis products and services to support cell and gene therapy development.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales

AI Layer

Application

Keywords

genomic structural variationdirected genomic hybridizationdGHcytogeneticssingle-cell analysisgenomic integritygene editingchromosomal rearrangementfluorescence in situ hybridizationFISHgenomic screeningcontract research organizationCROgenomic probesbioinformatics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

KromaTiD Comps

Public and private peers based on sector, stage, and business model.

KromaTiD comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

KromaTiD Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CAug 20, 2025
Corporate FundingApr 21, 2021
Series AAug 13, 2019
GrantJun 10, 2019

KromaTiD Investors

Notable investors and investment history

KromaTiD investors
InvestorRounds
NIH RADxGrant
First Capital VenturesSeries A
BroadOak Capital PartnersSeries C, Corporate Funding

KromaTiD Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

KromaTiD Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about KromaTiD's valuation, stock price, and market status.

Firmographic Details

HeadquartersBoulder, Colorado
Employee Range37
Year Founded2007
Last FundingAug 20, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.